NCT03535168 - Repeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 29, 2018

Primary Completion Date

September 25, 2019

Study Completion Date

October 11, 2019

Conditions

Cough

Interventions

DRUG

BAY1902607

3 different doses over the course of part 1 and 4 different doses over the course of part 2.

DRUG

Matching placebo

Matching placebo for BAY1902607

DRUG

Midazolam

Part 1: The subjects will initially (Day -1) receive a sub-therapeutic dose of 1 mg midazolam as solution in the morning.

Trial Locations (8)

Catharina Ziekenhuis, Eindhoven

Isala, Zwolle

Queen's University, Belfast

Birmingham Heartlands Hospital, Birmingham

Castle Hill Hospital, Cottingham

King's College Hospital - NHS Foundation Trust, London

Medicines Evaluation Unit, Manchester

University Hospital of South Manchester, Manchester